ED Decision 2019/002/R
(a) Applicants should undergo pulmonary morphological or functional tests when clinically indicated.
(b) Asthma and chronic obstructive pulmonary disease
Applicants with asthma or impairment of pulmonary function may be assessed as fit provided that the condition is considered stable with satisfactory pulmonary function and medication is compatible with flight safety. Systemic steroids may be acceptable provided that the dosage required is acceptable and there are no adverse side effects.
(1) Applicants with active sarcoidosis should be assessed as unfit. Investigation should be undertaken with respect to the possibility of systemic involvement. A fit assessment may be considered once the disease is inactive.
(2) Applicants with cardiac sarcoidosis should be assessed as unfit.
(1) Applicants with spontaneous pneumothorax may be assessed as fit subject to satisfactory respiratory evaluation following recovery from a single spontaneous pneumothorax or following recovery from surgical intervention for a recurrent pneumothorax.
(2) Applicants with traumatic pneumothorax may be assessed as fit following recovery.
Applicants who have undergone thoracic surgery may be assessed as fit following recovery.
(f) Sleep apnoea syndrome/sleep disorder
Applicants with unsatisfactorily treated sleep apnoea syndrome should be assessed as unfit.
AMC3 MED.B.095 details respiratory fitness standards for LAPL applicants, covering asthma, sarcoidosis, pneumothorax, thoracic surgery, and sleep apnoea, with fit/unfit criteria based on stability and recovery.
* Summary by Aviation.Bot - Always consult the original document for the most accurate information.
Loading collections...